severe < severity < sex

Facettes :

List of bibliographic references indexed by severity

Number of relevant bibliographic references: 17.

Ident.	Authors (with country if any)	Title
000124 (2011)	Zhihua Liu [États-Unis] ; Jinwoo Lee [États-Unis] ; Scott Krummey [États-Unis] ; Wei Lu [États-Unis] ; Huaibin Cai [États-Unis] ; Michael J. Lenardo [États-Unis]	The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
000328 (2011)	F. Stocchi [Italie] ; J. M. Rabey [Israël]	Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease
000746 (2010)	M. L. Houben [Pays-Bas] ; F. E. J. Coenjaerts [Pays-Bas] ; J. W. A. Rossen [Pays-Bas] ; M. E. Belderbos [Pays-Bas] ; R. W. Hofland [Pays-Bas] ; J. L. L. Kimpen [Pays-Bas] ; L. Bont [Pays-Bas]	Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community
000939 (2009)	Pablo Martínez-Martín [Espagne] ; Carmen Rodríguez-Blázquez [Espagne] ; Maria João Forjaz [Espagne] ; Jesús De Pedro [Espagne]	The clinical impression of severity index for Parkinson's disease: International validation study
001290 (2006)	Pablo Martínez-Martín [Espagne] ; M. João Forjaz [Espagne] ; Esther Cubo [Espagne] ; Belén Frades [Espagne] ; Jesús De Pedro Cuesta [Espagne]	Global versus factor‐related impression of severity in Parkinson's disease: A new clinimetric index (CISI‐PD)
001441 (2005)	Louise M. Allan [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni]	Prevalence and Severity of Gait Disorders in Alzheimer's and Non‐Alzheimer's Dementias
001443 (2005)	Manolis Markianos [Grèce] ; Marios Panas [Grèce] ; Nikos Kalfakis [Grèce] ; Dimitrios Vassilopoulos [Grèce]	Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia
001808 (2003)	Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]	Age and severity of nigrostriatal damage at onset of Parkinson's disease
001809 (2003)	Stefano Tamburin [Italie] ; Antonio Fiaschi [Italie] ; Domenico Idone [Italie] ; Piergiorgio Lochner [Italie] ; Paolo Manganotti [Italie] ; Giampietro Zanette [Italie]	Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: A TMS study
001922 (2002)	Gilberto Levy ; Nicole Schupf [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote ; Elan D. Louis ; Helen Mejia ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]	Combined effect of age and severity on the risk of dementia in Parkinson's disease
001B10 (2001)	P. K. Pal [Canada] ; C. S. Lee [Canada] ; A. Samii [Canada] ; M. Schulzer [Canada] ; A. J. Stoessl [Canada] ; E. K. Mak [Canada] ; J. Wudel [Canada] ; T. Dobko [Canada] ; J. K. C. Tsui [Canada]	Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [18F]-DOPA Ki
001D15 (1999)	E. Kraft [Allemagne, États-Unis] ; J. Winkelmann [Allemagne] ; C. Trenkwalder [Allemagne] ; D. P. Auer [Allemagne]	Visual hallucinations, white matter lesions and disease severity in Parkinson's disease
002339 (1995)	Seibyl [États-Unis] ; K. L. Marchek [États-Unis] ; D. Quinlan [États-Unis] ; K. Sheff [États-Unis] ; S. Zoghbi [États-Unis] ; Y. Zea-Ponce [États-Unis] ; R. M. Baldwin [États-Unis] ; B. Fussell [États-Unis] ; E. O. Smith [États-Unis] ; D. S. Charney [États-Unis] ; P. B. Hoffer [États-Unis] ; R. B. Innis [États-Unis]	Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease
002466 (1993-10-01)	J G Van Dijk [Pays-Bas] ; J. Haan [Pays-Bas] ; K. Zwinderman [Pays-Bas] ; B. Kremer [Pays-Bas] ; B J Van Hilten [Pays-Bas] ; R A Roos [Pays-Bas]	Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity.
002505 (1993)	Anton Mesec [Slovénie] ; Saša Šega [Slovénie] ; Tomaž Kiauta [Slovénie]	The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses
002699 (1991)	D. Prell [États-Unis] ; K. Khandelwal [États-Unis] ; S. Burns [États-Unis] ; P. Blandina [États-Unis] ; M. Morrishow [États-Unis] ; P. Green [États-Unis]	Levels of pros -methylimidazoleacetic acid: Correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice
002753 (1990)	G. Ransmayr [Autriche] ; W. Bitschnau [Autriche] ; B. Schmidhuber-Eiler [Autriche] ; W. Berger [Autriche] ; E. Karamat [Autriche] ; Werner Poewe [Autriche] ; W. Kemmler [Autriche]	Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptoms

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "severity" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "severity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    severity
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024